Clinical Trial

High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)

Study acronym: CARESTAR
Recruiting
View on ClinicalTrials.gov →
Summary
Goal is to analyse the clinical safety and efficacy of the CARESTO® heal Stent within standard clinical routine for the treatment of patients with symptomatic non-stenotic carotid disease (SyNC) and with high-risk plaque features for stroke recurrence compared to medical treatment alone with respect to the mid- and long-term clinical outcomes.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-09; most recent amendment 2026-03-03.
Status change: Not Yet Recruiting → Recruiting 2026-03-03
Trial Details
NCT Number NCT07166731
Lead Sponsor Acandis GmbH
Conditions Carotid Artery Disease, Symptomatic Carotid Artery Stenosis, Carotid Artery Stenting, Carotid Plaque Imaging, Embolic Stroke of Undetermined Source, Carotid Artery Thrombosis
Enrollment 536 participants
Start Date 2026-03-01
Primary Completion 2032-05-31 (estimated)
Study Completion 2032-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-04